These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 22720752)
1. PIM-1 kinase interacts with the DNA binding domain of the vitamin D receptor: a further kinase implicated in 1,25-(OH)2D3 signaling. Maier CJ; Maier RH; Rid R; Trost A; Hundsberger H; Eger A; Hintner H; Bauer JW; Onder K BMC Mol Biol; 2012 Jun; 13():18. PubMed ID: 22720752 [TBL] [Abstract][Full Text] [Related]
2. Thyroid hormone receptor does not heterodimerize with the vitamin D receptor but represses vitamin D receptor-mediated transactivation. Raval-Pandya M; Freedman LP; Li H; Christakos S Mol Endocrinol; 1998 Sep; 12(9):1367-79. PubMed ID: 9731705 [TBL] [Abstract][Full Text] [Related]
3. DDX5 is a multifunctional co-activator of steroid hormone receptors. Wagner M; Rid R; Maier CJ; Maier RH; Laimer M; Hintner H; Bauer JW; Onder K Mol Cell Endocrinol; 2012 Sep; 361(1-2):80-91. PubMed ID: 22476084 [TBL] [Abstract][Full Text] [Related]
4. 1,25-Dihydroxyvitamin D3 stimulates cyclic vitamin D receptor/retinoid X receptor DNA-binding, co-activator recruitment, and histone acetylation in intact osteoblasts. Kim S; Shevde NK; Pike JW J Bone Miner Res; 2005 Feb; 20(2):305-17. PubMed ID: 15647825 [TBL] [Abstract][Full Text] [Related]
5. Nongenotropic, anti-apoptotic signaling of 1alpha,25(OH)2-vitamin D3 and analogs through the ligand binding domain of the vitamin D receptor in osteoblasts and osteocytes. Mediation by Src, phosphatidylinositol 3-, and JNK kinases. Vertino AM; Bula CM; Chen JR; Almeida M; Han L; Bellido T; Kousteni S; Norman AW; Manolagas SC J Biol Chem; 2005 Apr; 280(14):14130-7. PubMed ID: 15671029 [TBL] [Abstract][Full Text] [Related]
6. Evidence for 1,25-dihydroxyvitamin D3-independent transactivation by the vitamin D receptor: uncoupling the receptor and ligand in keratinocytes. Ellison TI; Eckert RL; MacDonald PN J Biol Chem; 2007 Apr; 282(15):10953-62. PubMed ID: 17310066 [TBL] [Abstract][Full Text] [Related]
7. Potent vitamin D3 analogs: their abilities to enhance transactivation and to bind to the vitamin D3 response element. Imai Y; Pike JW; Koeffler HP Leuk Res; 1995 Mar; 19(3):147-58. PubMed ID: 7700077 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of 1,25-dihydroxyvitamin D3 stimulated osteocalcin gene transcription by tumor necrosis factor-alpha: structural determinants within the vitamin D response element. Kuno H; Kurian SM; Hendy GN; White J; deLuca HF; Evans CO; Nanes MS Endocrinology; 1994 Jun; 134(6):2524-31. PubMed ID: 8194478 [TBL] [Abstract][Full Text] [Related]
9. Enhancers located within two introns of the vitamin D receptor gene mediate transcriptional autoregulation by 1,25-dihydroxyvitamin D3. Zella LA; Kim S; Shevde NK; Pike JW Mol Endocrinol; 2006 Jun; 20(6):1231-47. PubMed ID: 16497728 [TBL] [Abstract][Full Text] [Related]
11. Lymphocyte cell lines from vitamin D-dependent rickets type II show functional defects in the 1 alpha,25-dihydroxyvitamin D3 receptor. Koeffler HP; Bishop JE; Reichel H; Singer F; Nagler A; Tobler A; Walka M; Norman AW Mol Cell Endocrinol; 1990 Mar; 70(1):1-11. PubMed ID: 2160380 [TBL] [Abstract][Full Text] [Related]
12. Transcriptional activity of a fluorinated vitamin D analog on VDR-RXR-mediated gene expression. Sasaki H; Harada H; Handa Y; Morino H; Suzawa M; Shimpo E; Katsumata T; Masuhiro Y; Matsuda K; Ebihara K Biochemistry; 1995 Jan; 34(1):370-7. PubMed ID: 7819220 [TBL] [Abstract][Full Text] [Related]
13. New understanding of the molecular mechanism of receptor-mediated genomic actions of the vitamin D hormone. Haussler MR; Jurutka PW; Hsieh JC; Thompson PD; Selznick SH; Haussler CA; Whitfield GK Bone; 1995 Aug; 17(2 Suppl):33S-38S. PubMed ID: 8579895 [TBL] [Abstract][Full Text] [Related]
14. 20,23-dihydroxyvitamin D3, novel P450scc product, stimulates differentiation and inhibits proliferation and NF-kappaB activity in human keratinocytes. Janjetovic Z; Tuckey RC; Nguyen MN; Thorpe EM; Slominski AT J Cell Physiol; 2010 Apr; 223(1):36-48. PubMed ID: 20020487 [TBL] [Abstract][Full Text] [Related]
15. The vitamin D hormone and its nuclear receptor: molecular actions and disease states. Haussler MR; Haussler CA; Jurutka PW; Thompson PD; Hsieh JC; Remus LS; Selznick SH; Whitfield GK J Endocrinol; 1997 Sep; 154 Suppl():S57-73. PubMed ID: 9379138 [TBL] [Abstract][Full Text] [Related]
16. Analysis of vitamin D analog-induced heterodimerization of vitamin D receptor with retinoid X receptor using the yeast two-hybrid system. Zhao XY; Eccleshall TR; Krishnan AV; Gross C; Feldman D Mol Endocrinol; 1997 Mar; 11(3):366-78. PubMed ID: 9058382 [TBL] [Abstract][Full Text] [Related]
17. Gene regulatory potential of nonsteroidal vitamin D receptor ligands. Peräkylä M; Malinen M; Herzig KH; Carlberg C Mol Endocrinol; 2005 Aug; 19(8):2060-73. PubMed ID: 15860548 [TBL] [Abstract][Full Text] [Related]
18. 1,25-Dihydroxyvitamin D Li M; Li L; Zhang L; Hu W; Shen J; Xiao Z; Wu X; Chan FL; Cho CH Life Sci; 2017 Jun; 179():88-97. PubMed ID: 28465245 [TBL] [Abstract][Full Text] [Related]
19. Interaction of two novel 14-epivitamin D3 analogs with vitamin D3 receptor-retinoid X receptor heterodimers on vitamin D3 responsive elements. Verlinden L; Verstuyf A; Quack M; Van Camp M; Van Etten E; De Clercq P; Vandewalle M; Carlberg C; Bouillon R J Bone Miner Res; 2001 Apr; 16(4):625-38. PubMed ID: 11315990 [TBL] [Abstract][Full Text] [Related]